Jazz Pharmaceuticals Announces Phase III Clinical Trial To Study The Safety And Efficacy Of Xyrem(R) In Patients With Fibromyalgia Syndrome

... Jazz Pharmaceuticalsannounced today the initiation of a Phase III clinical trial intended toevaluate the safety and efficacy of Xyrem(R) (sodium oxybate) oral solutionas a treatment for fibromyalgia syndrome. The randomized, double-blind, placebo-controlled study will evaluatethe safety and efficacy of Xyrem compared to placebo for the treatment offibromyalgia and its symptoms. [click link for full article] ...